Clinical and Clinical/Research Faculty
Kenneth Ataga, MD - General hematology; development of new therapies in sickle cell disease.
Lee Berkowitz, MD - Hematologic Malignancies; Director of the Internal Medicine Residency Program
Stephen Bernard, MD, FACP - GI Malignancies; palliative care and hospice program
Lisa Carey, MD - Breast Cancer; clinical/translational research in breast cancer including evaluation of novel drug combinations and clinical implications of molecular sub-typing
Frances Collichio, MD - Melanoma, Breast Cancer, Neuro-oncology and related Phase I/II studies; Associate Fellowship Director and Director for Fellowship Education
Terrance Comeau, MD - Bone Marrow Transplant and Information Technology
Elizabeth Claire Dees, MD - Breast Cancer and Phase I/Development Therapeutics
Paul Godley, MD, PhD, MPP - GU, epidemiology and nutritional causes of prostate cancer; minority outreach initiatives
Richard Goldberg, MD - Division Chief; GI Malignancies; developmental therapeutics and pharmacogenomics
David Neil Hayes, MD, MPH - Head and Neck Cancer, Thoracic oncology, bioinformatics and micro-array analysis in solid tumors
Raj Kasthuri, MD - Hemostasis and Thrombosis
Alice Ma, MD - Hemostasis and Thrombosis; platelet disorders; Associate Fellowship Program Director
Stephan Moll, MD - Hemostasis and Thrombosis, TTP
Bert O'Neil, MD - GI Malignancies; hepatic carcinomas; Phase I/developmental therapeutics and translational studies with NF Kappa B inhibitors
Eugene Orringer, MD, PhD - Sickle Cell disease; faculty and trainee development; institutional translational science efforts
Jeffrey Peppercorn, MD, MPH - Breast Cancer and outcomes analysis including clinical trial accrual and ethics in clinical research
Hanna Sanoff, MD - GI oncology; clinical research on chemotherapy in the elderly.
Thomas Shea, MD - Director of the Bone Marrow and Stem Cell Transplant Program; Director of the Fellowship Program; Associate Director for the Outreach Program - UNC- LCCC; clinical trials in hematologic malignancies
Cecile Skrzynia, MS, CGC - Cancer Genetics; Breast, GI and other inherited cancer genetics syndromes
Mark A Socinski, MD - Thoracic oncology clinical trials and Phase I studies
Thomas Stinchcombe, MD - Thoracic oncology and Phase I/ developmental therapeutics
Peter Voorhees, MD - Hematologic Malignancies; Phase I/developmental therapeutics, clinical and translational research in multiple myeloma and leukemia
Laboratory-Based Faculty
Don Gabriel, MD, PhD - Bone Marrow Transplant, hematologic malignancies, hemostasis, thrombosis and platelet activation
Nigel Key, MB, ChB, FRCP - Hemostasis and Thrombosis; hemophilia; endothelial cell and vascular damage; PI on the T32 training grant in hematology
William Kim, MD - GU cancer and basic investigations in hypoxia-inducible factor (HIF) in tumorigenesis
Kimryn Rathmell, MD, PhD - GU malignancies and laboratory investigations of carcinogenesis and tumor suppressor genes
Harold Roberts, MD - Hemostasis and Thrombosis and activation of tissue factor and initiators of the coagulation cascade
Jonathan Serody, MD - Bone Marrow Transplant; dendritic cell vaccine trials in breast cancer and basic laboratory interests in animal models of graft vs host disease and chemokine activation and regulation
Ned Sharpless, MD - Tumor suppressor gene regulation and expression, cell senescence, and genetics
Hank van Deventer, MD - Hematologic Malignancies and laboratory investigations in the role of chemokines in the development of tumor metastases
Young Whang, MD, PhD - GU malignancies; laboratory-based studies examining aberrant signal transduction pathways and loss of tumor suppressor genes such as PTEN in carcinogenesis
Research Faculty
Jen-Yea Chang, PhD - Hemostasis and Thrombosis
Lynn Dressler, PhD - Breast Cancer, Tissue Procurement
Nigel Mackman, PhD - Hemostasis and Thrombosis
Dougald Monroe, III, PhD - Hemostasis and Thrombosis, endothelial cell biology and mechanisms of vascular repair
Physicians Assistants & Family Nurse Practitioners
Chip Baker, MS, RN, ANP-C - Palliative Care
Robert Irons, PA - Bone Marrow Transplant
Anna Kate Owens, NP - Breast Cancer
John Strader, PA - Hematologic Malignancies
Dell Strayhorn, FNP - Sickle Cell
Tammy Triglianos, NP - GI Malignancies
Lineberger Comprehensive Cancer Center Specific Programs and Leaders
Cancer Cell Biology: Al Baldwin, PhD
Cancer Epidemiology: Andrew Olshen, PhD
Cancer Genetics: Terry Magnuson, PhD
Cancer Prevention/Control: Marci Campbell, PhD
Clinical Research: Richard Goldberg, MD and Thomas Shea, MD
Immunology: Jenny Ting, PhD and Jon Serody, MD co-program leaders
Molecular Carcinogenesis: David Kaufman, MD, PhD
Molecular Therapeutics: Gary Johnson, PhD
Virology: Nancy Rabb-Traub, PhD
Laboratory-based faculty in the Lineberger Comprehensive Cancer Center who have mentored Fellow trainees in their laboratories:
Adrienne Cox, PhD - molecular mechanisms of cancer biology, particularly concerning members of the Ras superfamily of protein
Blossom Damonia, PhD - molecular pathogenesis of Kaposi's sarcoma-associated herpesvirus (KSHV)
Channing Der, PhD - Ras family oncogene proteins and on the discovery of novel oncogenes involved in specific human cancers
Shelton Earp, MD - tryosine-specific protein kinases in breast and prostate cancer, as well as lymphoma/leukemia
Jim Evans, MD, PhD - Director of Cancer Genetics. Breast and colon cancer genetics, pharmacogenomics, patient attitudes regarding risk and testing.
Jeffrey Frelinger, PhD - understanding how major histocompatibility complex (MHC) molecules function in the immune response to pathogens
William Kaufmann, PhD - determining the mechanisms whereby cell cycle checkpoints suppress human carcinogenesis
Howard McLeod, PharmD - Pharmacogenomics and individualized therapy through genomic profiling
Chuck Perou, PhD - characterize the biological diversity of human tumors using DNA microarrays, molecular genetics, and cell biology, in order to develop therapies that are specific to each tumor subtype
Carolyn Sartor, MD - study of the epidermal growth factor receptor (EGFR) family, specifically the role these proteins play in breast cancer development and response to radiotherapy
Bernard Weissman, PhD - Chromatin remodeling complexes play a key role in the regulation of cellular transcription by modulating access of proteins to DNA
Yue Xiong, PhD - understanding mechanism(s) controlling cell cycle progression in normal human cells, and how this control is being altered during tumorigenesis
Yi Zhang, PhD - how epigenetic-mediated dynamic changes in chromatin structure affect gene expression, cell lineage commitment and cancer development
For additional Lineberger Comprehensive Cancer Center based research programs with potential training opportunities in basic, clinical, translational and population-based research please visit their site at cancer.med.unc.edu